HELICOBACTER PYLORI INFECTION AND ASSOCIATED DISEASE AT DIFFERENT AGES AND SEX

S. Sagdati ,
S. Sagdati

General Hospital Novi Pazar , Novi Pazar , Serbia

S. Milinić
S. Milinić

Medical faculty Priština , Kosovska Mitrovica , Kosovo*

Published: 01.01.2010.

Volume 38, Issue 1 (2010)

pp. 87-90;

https://doi.org/10.70949/pramed201001333S

Abstract

The discovery of Helicobacter pylori (Hp) and the causal relationship between Helicobacter pylori infection with chronic gastritis, gastric and duodenal ulcers and gastric cancer is an epochal event in recent times. The aim of this study was to examine the prevalence of Hp infection and prove the connection between Helicobacter pylori infection and gastric and duodenal diseases in different age and gender categories. Study included 250 subjects of both sexes, different age groups selected random sample. All respondents were subjected to Hp urease test from biopsy specimens of the antrum and corpus of the stomach obtained by upper gastrointestinal endoscopy with standard forceps. The data were analyzed using descriptive statistical methods (CF, SD, Min, Max) and analytical statistical methods. (t test, Chi square test, Kruskal-Wallis test, MannWhitney U test, Wilcoxon test, analysis of variance, ANOVA, Spearman correlation and Persona). Non ulcer gastropathy was the dominant finding that the Hp urease negative (92.2%) and the Hp urease positive (77%)respondents .Duodenalni ulcer was common in the male sex (24.6%) and gastric cancer (2.9%), and stomach ulcer was common in women (4.5%). The most common representation non ulcer gastropathy in the fifth and sixth decades of life while duodenal ulcer was most common in the fifth decade (37.5%). Gastric ulcer was noted in the second, third and fourth decade of life. Gastric cancer is 100% of cases was recorded in the sixth decade of life. Hp Urease test that requires upper digestive endoscopy and biopsy specimens of gastric mucosa is the minimum invasive diagnosis of Helicobacter pylori infection. Upper gastrointestinal endoscopy and HP verification changes the standard in the diagnosis of associated diseases of the stomach and duodenum. (non ulcer gastropathy, gastric and duodenal ulcers and gastric cancer).

Keywords

References

1.
Labenz J, Tillenburg B, Peitz U, Borch G. Long-term consequences of Helicobacter pylori eradication: Clinical aspects. Scand J Gastroenterol. 31(suppl 215):111–5.
2.
Talley NJ, Zinsmeister AR, Weaver A. Gastric adenocarcinoma and Helicobacter pylori. J Natl Cancer Inst. 83:1734–9.
3.
Sokić A. Gastrin i somatostatin u Helicobacter pylori infekciji—klinička, imunohistohemijska i elektronskomikroskopska studija. In: Magistarski rad Univerzitet u Beogradu, Medicinski fakultet.
4.
Petrović V. Procena dijagnostičkih vrednosti sopstvenog brzog ureaza testa u odnosu na različite histološke načine dokazivanja Helicobacter pylori infekcije. Magistarski rad.
5.
Milosavljević T, Jovanović D, Petrović V. Helicobacter pylori: 100 pitanja i odgovora.
6.
Dandesign i Medicinski fakultet.
7.
Milosavljević T. Helicobacter pylori u kliničkoj praksi.
8.
Milosavljević T. Helicobacter pylori i oboljenja digestivnog sistema: Petnaest godina kasnije. Arch Gastroenterohepatol.
9.
Mijalković N. Klinički značaj povezanosti Helicobacter pylori infekcije i ulkusne bolesti želuca. In: Magistarski rad Univerzitet u Beogradu, Medicinski fakultet.
10.
11.
Marshall BJ. Helicobacter pylori. Am J Gastroenterol. 89(suppl).
12.
Marshall BJ, Warren. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1:1311–5.
13.
Marshall BJ, Royce H, Anner D. Original isolation of Campylobacter pyloridis from human gastric mucosa. Microbios Lett. 25:83–8.
14.
Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1:1273–5.
15.
Armstrong D. Helicobacter pylori infection and dyspepsia. Scand J Gastroenterol. 3(suppl 201):38–47.
16.
17.
Kanjamura T, Fujimura S. The prevalence of Helicobacter pylori infection in Tibetans. Gut. 53(suppl VI).
18.
Jovanović I. Klinička studija povezanosti Helicobacter pylori infekcije i sindroma gornje dispepsije. In: Magistarski rad Univerzitet u Beogradu, Medicinski fakultet.
19.
Jovanović DM, Bulajić M, Milosavljević T, Vranješ N. Helicobacter pylori infekcija. Arch Gastroenterohepatol. 15(suppl 7):22–3.
20.
Jovanović D. Helicobacter pylori infekcija kao faktor rizika u pojavi maligniteta želuca. In: Prevencija malignih oboljenja digestivnih organa.
21.
Harris ANJ, Misienjicz GJJ. Helicobacter pylori.
22.
Gisbert JP, Pajares JM, Racz I. Therapy. Curr Opin Gastroenterol. 7.
23.
Kliničke GS. endoskopske i histološke karakteristike oboljenja gastroduodenuma u pacijentima sa Helicobacter pylori infekcijom. In: Doktorska disertacija Univerzitet u Nišu, Medicinski fakultet.
24.
25.
Cazzato IA, Nista EC, Fini L. New options for Helicobacter pylori eradication: modified clarithromycin-based strategies. Gut. 53(suppl VI).
26.
Bazzoli F. Key points from the revised Maastricht consensus report: the impact on general practice. Eur J Gastroenterol Hepatol. 13(suppl 2):3–7.
27.
Adžon ATR. A guide to Helicobacter pylori.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by